The seemingly never-ending COVID-19 shutdowns and restrictions have put countless plans on hold. In many cases, those plans have included regular cancer screenings — particularly screening for breast cancer, which has fallen by nearly 50%. As we know, the key to beating metastatic breast cancer is early detection. Delayed diagnoses give cancer more time to spread before it’s caught, reducing chances of survival. In fact, the National Cancer Institute (NCI) estimates more than 10,000 additional deaths from breast and colorectal cancer over the next 10 years because of these delayed screenings.